Biopharma 2020: A landmark year and a reset for the future
Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? McKinsey biopharma 2020 3 Overarching trends Operating under a spotlight - expectation of innovationNavigating protracted economic uncertainty -...
Source: mckinsey.com
Outcomes Standardisation Project (OSP) for Continuing Medical Education (CE/CME) Professionals:
Despite an increased focus and urgency for CE/CME professionals to effectively and systematically assess the impact of their educational interventions, the community has struggled to do so. This struggle is in large part due to the lack of a standardised outcomes language and a set of unified approaches.
Source: nih.gov
What to Learn from US Govt Strategy on AI. There is an urgency. It's commercial. China is already in the lead. There is
What to Learn from US Govt Strategy on AI. There is an urgency. It's commercial. China is already in the lead. There is no clear vision where to focus funding. The US has a good roadmap and wants to expand the workforce. The US is not going for general intelligence. "On October 12, 2016, President...
Source: digitopoly.org
RSS feed